Design, recruitment, and retention of African-American smokers in a pharmacokinetic study

BMC Medical Research Methodology

Volumn 10, Issue , 2010, Pages

  Faseru, Babalola ^a   Cox, Lisa S ^a   Bronars, Carrie A ^a   Opole, Isaac ^a   Reed, Gregory A ^b   Mayo, Matthew S ^a   Ahluwalia, Jasjit S ^c   Okuyemi, Kolawole S ^c,d  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; MENTHOL;

AFRICAN AMERICAN; ARTICLE; ETHNOLOGY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLISM; METHODOLOGY; PATIENT ATTITUDE; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; SMOKING; TECHNIQUE;

AFRICAN AMERICANS; BUPROPION; FEMALE; HUMANS; MALE; MENTHOL; METHODS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; RESEARCH DESIGN; SMOKING;

EID: 77649300536     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-10-6     Document Type: Article

References (56)

1. Healthy people 2000: National health promotion and disease prevention objectives full report with commentary. USDHHS, Washington, D.C.: Government Printing Office 1991
2. Health Disparities Experienced by Black or African-Americans - United States. CDC, MMWR 2005 54 01 1 3
3. Clinical trial participation: Viewpoints from racial/ethnic groups. NL Roberson, Cancer 1994 74 Suppl 9 2687 2691
4. Inclusion of black Americans in oncology clinical trials: the Louisiana State University Medical Center experience. RF Holcombe J Jacobson A Li CM Moinpour, Am J Clin Oncol 1999 22 1 18 21 10.1097/00000421-199902000-00005 10025373
5. Recruiting minorities into clinical trials: toward a participant-friendly system. GM Swanson AJ Ward, J Natl Cancer Inst 1995 87 23 1747 1759 10.1093/jnci/87.23.1747 7473831
6. Recruitment and retention of African American elders into community-based research: lessons learned. BP Dennis JB Neese, Arch Psychiatr Nurs 2000 14 1 3 11 10.1016/S0883-9417(00)80003-5 10692801
7. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. B Evelyn T Toigo D Banks D Pohl K Gray B Robins J Ernat, J Natl Med Assoc 2001 93 Suppl 12 18 S24
8. Clinical trials. Concerns of the patient and the public. PA Ganz, Cancer 1990 65 Suppl 10 2394 2399 10.1002/1097-0142(19900515)65:10+<2394::AID- CNCR2820651509>3.0.CO;2-# 2185874
9. Participation of minorities in cancer research: the influence of structural, cultural, and linguistic factors. AR Giuliano N Mokuau C Hughes G Tortolero-Luna B Risendal RCS Ho TE Prewitt WJ McCaskill-Stevens, Ann Epidemiol 2000 10 Suppl 8 22 S34 10.1016/S1047-2797(00)00195-2 11189089
10. Racial disparities in clinical trials. TE King Jr, N Engl J Med 2002 346 18 1400 1402 10.1056/NEJM200205023461812 11986416
11. Making medicines for America: the case for clinical trial diversity. JH Powell Y Fleming, J Natl Med Assoc 2000 92 11 507 514 11152082
12. Why are African Americans under-represented in medical research studies? Impediments to participation. VL Shavers-Hornaday CF Lynch LF Burmeister JC Torner, Ethn Health 1997 2 1-2 31 45 9395587
13. Increasing participation of minorities in cancer clinical trials: summary of the "Moving Beyond the Barriers" Conference in North Carolina. N Stark E Paskett R Bell MR Cooper E Walker A Wilson C Tatum, J Natl Med Assoc 2002 94 1 31 39 11837350
14. Representation of American blacks in clinical trials of new drugs. CK Svensson, JAMA 1989 261 2 263 265 10.1001/jama.261.2.263 2909024
15. The challenge of minority recruitment in clinical trials for AIDS. W El-Sadr L Capps, JAMA 1992 267 7 954 957 10.1001/jama.267.7.954 1734108
16. Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered. LA Moyé JH Powell, J Natl Med Assoc 2001 93 Suppl 12 29S 34S 11798062
17. Hormone replacement therapy for African American women: missed opportunities for effective intervention. WK Nicholson AF Brown J Gathe K Grumbach AE Washington EJ Pérez-Stable, Menopause 1999 6 2 147 155 10.1097/00042192-199906020-00012 10374222
18. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. RB D'Agostino Sr S Grundy LM Sullivan P Wilson CHD Risk Prediction Group, JAMA 2001 286 2 180 187 10.1001/jama.286.2.180 11448281
19. Participation of African Americans in clinical research. GJ Bonner TP Miles, Neuroepidemiology 1997 16 6 281 284 10.1159/000109698 9430127
20. The recruitment triangle: reasons why African Americans enroll refuse to enroll, or voluntarily withdraw from a clinical trial. PB Gorelick Y Harris B Burnett FJ Bonecutter, J Natl Med Assoc 1998 90 3 141 145 9549977
21. The recruitment of African Americans to cancer prevention and control studies. ED Paskett C DeGraffinreid CM Tatum SE Margiti Prev Med 1996 25 5 547 553 10.1006/pmed.1996.0088 8888322
22. Recruiting and retaining minority women: findings from the Women on the Move study. SL Escobar-Chaves SR Tortolero LC Msse KB Watson JE Fulton, Ethn Dis 2002 12 2 242 251 12019934
23. Attitudes and beliefs of African Americans toward participation in medical research. G Corbie-Smith SB Thomas MV Williams S Moody-Ayers, J Gen Intern Med 1999 14 9 537 546 10.1046/j.1525-1497.1999.07048.x 10491242
24. Distrust, race, and research. G Corbie-Smith SB Thomas DM St George, Arch Intern Med 2002 162 21 2458 2463 10.1001/archinte.162.21.2458 12437405
25. Barriers to black women's participation in cancer clinical trials. CP Mouton S Harris S Rovi P Solorzano MS Johnson, J Natl Med Assoc 1997 89 11 721 727 9375475
26. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. Cholesterol Reduction in Seniors Program. DB Stoy RC Curtis KS Dameworth AA Dowdy J Hegland JA Levin BG Sousoulas, J Natl Med Assoc 1995 87 4 280 287 7752281
27. Race and sex differences in lung cancer risk associated with cigarette smoking. RE Harris EA Zang JI Anderson EL Wynder, Int J Epidemiol 1993 22 4 592 599 10.1093/ije/22.4.592 8225730
28. Smoking cessation in U.S. ethnic minority populations. K Okuyemi L Cox WS Choi JS Ahluwalia, VA in the Vanguard: Building on Success in Smoking Cessation, Isaacs SL, 2005
29. A survey of smoking and quitting patterns among black Americans. CT Orleans VJ Schoenbach MA Salmon VJ Strecher W Kalsbeek D Quade EF Brooks TR Konrad C Blackmon CD Watts, Am J Public Health 1989 79 2 176 181 10.2105/AJPH.79.2.176 2913836
30. Mentholated cigarette use among multiphasic examinees 1979-86. S Sidney I Tekawa GD Friedman, Am J Public Health 1989 79 10 1415 6 10.2105/AJPH.79.10. 1415 2782516
31. Cigarette advertising and black-white differences in brand preference. KM Cummings G Giovino AJ Mendicino, Public Health Rep 1987 102 6 698 701 3120235
32. Does menthol attenuate the effect of bupropion among African American smokers? KS Okuyemi JS Ahluwalia M Ebersole-Robinson D Catley MS Mayo K Resnicow, Addiction 2003 98 10 1387 1393 10.1046/j.1360-0443.2003.00443.x 14519175
33. Relationship between menthol cigarettes and smoking cessation among African American light smokers. KS Okuyemi B Faseru L Sanderson Cox CA Bronars JS Ahluwalia, Addiction 2007 102 12 1979 1986 10.1111/j.1360-0443.2007.02010.x 17916223
34. Baseline characteristics and recruitment strategies in a randomized clinical trial of African-American light smokers. KS Okuyemi LS Cox NL Nollen TM Snow H Kaur W Choi N Nazir MS Mayo JS Ahluwalia, Am J Health Promot 2007 21 3 183 191 17233236
35. Design and baseline characteristics from the KAN-QUIT disease management intervention for rural smokers in primary care. LS Cox AP Cupertino LM Mussulman N Nazir KA Greiner JD Mahnken JS Ahluwalia EF Ellerbeck, Prev Med 2008 47 2 200 205 10.1016/j.ypmed.2008.04.013 18544464
36. Smoking cessation pharmacotherapy preferences in rural primary care. PA Cupertino KP Richter LS Cox N Nazir AK Greiner JS Ahluwalia EF Ellerbeck, Nicotine Tob Res 2008 10 2 301 307 10.1080/14622200701825817 18236294
37. Successful recruitment of minorities into clinical trials: The Kick It at Swope project. KJ Harris JS Ahluwalia D Catley KS Okuyemi MS Mayo K Resnikow, Nicotine Tob Res 2003 5 4 575 84 10.1080/1462220031000118540 12959796
38. Knowledge about smoking reasons for smoking, and reasons for wishing to quit in inner-city African Americans. JS Ahluwalia K Resnicow WS Clark, Ethn Dis 1998 8 3 385 393 9926909
39. Smoking cessation among inner-city African Americans using the nicotine transdermal patch. JS Ahluwalia SE McNagny WS Clark, J Gen Intern Med 1998 13 1 1 8 10.1046/j.1525-1497.1998.00001.x 9462488
40. African American smokers interested and eligible for a smoking cessation clinical trial: predictors of not returning for randomization. JS Ahluwalia K Richter MS Mayo HK Ahluwalia WS Choi KH Schmelzle K Resnicow, Ann Epidemiol 2002 12 3 206 212 10.1016/S1047-2797(01)00305-2 11897179
41. Participation of African Americans in a smoking cessation trial: a quantitative and qualitative study. MN Woods KJ Harris MS Mayo D Catley M Scheibmeir JS Ahluwalia, J Natl Med Assoc 2002 94 7 609 618 12126287
42. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JS Ahluwalia KJ Harris D Catley KS Okuyemi MS Mayo, JAMA 2002 288 4 468 474 10.1001/jama.288.4.468 12132977
43. Smoking reduction practices among African American smokers. KS Okuyemi KP Richter JS Ahluwalia MC Mosier N Nazir K Resnicow, Nicotine Tob Res 2002 4 Suppl 2 167 173 10.1080/1462220021000032744 12573177
44. Perceptions of smoking among African American light smokers. KS Okuyemi M Scheibmeir J Butler JS Ahluwalia, Subst Abus 2003 24 3 191 193 12913368
45. Predicting adoption of home smoking restriction by inner-city black smokers. FA Okah KS Okuyemi KS McCarter KJ Harris D Catley H Kaur JS Ahluwalia, Arch Pediatr Adolesc Med 2003 157 12 1202 1205 10.1001/archpedi.157.12.1202 14662576
46. Differences in smoking and quitting experiences by levels of smoking among African Americans. KS Okuyemi JS Ahluwalia R Banks KJ Harris MC Mosier N Nazir J Powell, Ethn Dis 2004 14 1 127 133 15002932
47. Predictors of smoking cessation among African-Americans enrolled in a randomized controlled trial of bupropion. KJ Harris KS Okuyemi D Catley MS Mayo B Ge JS Ahluwalia, Prev Med 2004 38 4 498 502 10.1016/j.ypmed.2003.12.008 15020185
48. Religiosity, social support, and smoking cessation among urban African American smokers. NL Nollen D Catley G Davies M Hall JS Ahluwalia, Addict Behav 2005 30 6 1225 1229 10.1016/j.addbeh.2004.10.004 15925130
49. Relationship between menthol cigarettes and smoking cessation among African American light smokers. KS Okuyemi B Faseru L Sanderson Cox CA Bronars JS Ahluwalia, Addiction 2007 102 12 1979 1986 10.1111/j.1360-0443.2007.02010.x 17916223
50. Achieving high rates of consent for genetic testing among African American smokers. LS Cox CA Bronars JL Thomas KS Okuyemi G King MS Mayo JS Ahluwalia, Nicotine Tob Res 2007 9 6 711 716 10.1080/14622200701365228 17558828
51. Enhanced cue-elicited brain activation in African American compared with Caucasian smokers: an fMRI study. KS Okuyemi JN Powell CR Savage SB Hall N Nollen LM Holsen FJ McClernon JS Ahluwalia, Addict Biol 2006 11 1 97 106 10.1111/j.1369-1600.2006.00007.x 16759342
52. The effects of nicotine gum and counseling among African American light smokers: a 2 × 2 factorial design. JS Ahluwalia K Okuyemi N Nollen WS Choi H Kaur K Pulvers MS Mayo, Addiction 2006 101 6 883 891 10.1111/j.1360-0443. 2006.01461.x 16696632
53. Smoking in urban African Americans: behaviors, gender differences and motivation to quit. MN Woods KJ Harris JS Ahluwalia KH Schmelzle MS Mayo, Ethn Dis 2001 11 3 532 539 11572418
54. Predictors of quitting among African American light smokers enrolled in a randomized, placebo-controlled trial. NL Nollen MS Mayo L Sanderson Cox KS Okuyemi WS Choi H Kaur JS Ahluwalia, J Gen Intern Med 2006 21 6 590 595 10.1111/j.1525-1497.2006.00404.x 16808741
55. Predictors of participant adherence and retention in the African American Study of Kidney Disease and Hypertension. D Brooks J Charleston D Dowie A Gabriel YB Hall L Hiremath T Lightfoot M Sika WC Smith X Wang, Nephrol Nurs J 2008 35 2 133 42 18472682
56. Use of mentholated cigarettes and lung cancer risk. GC Kabat JR Hebert, Cancer Res 1991 51 24 6510 3 1742723